Developer docs
API playgroundTry for free, no card

Search company profiles

Photon8

Full company profile

uuid0034244

Namestring
Photon8
Legal namestring
Photon8
Websiteurl
photon8.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Photon8 is a privately held industrial biotechnology company headquartered in Corpus Christi, Texas, developing algae-based production systems for lipids, proteins, and minerals. The company uses autotrophic photosynthesis to convert photons, CO2, and waste-stream nutrients into algae biomass, with near-term planned market entry in Omega-3 fatty acid products targeting the nutritional supplements and health products segment. Operations are physically anchored at Texas A&M University-Corpus Christi (TAMU-CC), where the company runs culturing facilities, lab-scale reactors, and outdoor production units, and are supplemented by a partnership with Louisiana State University for exclusive downstream processing technology. The company has been supported by the Shell GameChanger program, which enabled the buildout at TAMU-CC.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersCorpus Christi, United States
HQ citystring
Corpus Christi
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
algae biotechnology, omega-3 production, algae biomass cultivation, carbon capture systems, sustainable biofuels
Industry3 codes
PRIMARYAFAEAAAE
Seaweed & Algae Aquaculture (incl. microalgae)
Agriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)
SECONDARYEUABAIAJ
Biological CO₂ Utilization (algae/biotech conversion to fuels, chemicals, proteins)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/CO₂ Utilization & Carbon-to-Value (E-fuels, Chemicals, Building Materials)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)
NAICS code2 codes
  • Aquaculture1125
  • Aquaculture11251
Product category
Algae-based biotechnology / Industrial biotech manufacturing
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1Omega-3 Products
TypeHardware Sales
Description

Upcoming market entry focusing on Omega-3 production derived from algae biomass. The company is developing its commercial production capabilities ahead of launch.

photon8.com
2Algae Biomass Products
TypeHardware Sales
Description

Products containing lipids, proteins, and minerals extracted from autotrophic algae through proprietary processes.

photon8.com
Marketing channels1 record

Each record includes

Title, Type, Stage, Description, Source

Cost components4 values
Technology or R&D, Operations, Personnel, Infrastructure
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Core offering1 text field

Photon8 develops and operates an algae-based biotechnology platform that uses proprietary Parallel Film Reactor (PFR) systems with Traveling Wave Technology to cultivate autotrophic algae, converting photons, CO2, and nutrients into biomass rich in lipids, proteins, and minerals. The company pairs this with genetically enhanced algae strains and a chemical-free Aqueous Extraction process, with upcoming market entry focused on Omega-3 fatty acid production for nutritional supplements and broader sustainable-industry applications.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 3 values shown
  • 100x reduction in capital and operating expenses compared to conventional algae biofuel approaches
+2 more records
Product overview1 text field

Photon8 offers an integrated algae cultivation and processing system centered on its Parallel Film Reactor (PFR) technology with Traveling Wave Technology for closed-system algae growth, combined with genetically enhanced algae strains optimized for lipid production, and Aqueous Extraction for chemical-free lipid recovery. The company is positioning for market entry in Omega-3s, positioning itself as a sustainable alternative to conventional algae biofuels and omega-3 production approaches.

Product and service5 records
1Parallel Film Reactor (PFR) with Traveling Wave Technology
CategoryAlgae cultivation hardware / Bioreactor system
Description

Patent-pending closed algae cultivation system offering closed-system performance at under $10/m2, with full CO2 utilization and contamination resistance. Used by Photon8 and intended customers as the production backbone for algae-derived products.

2Aqueous Extraction Process
CategoryDownstream processing technology / Extraction
Description

Chemical-free water-based lipid extraction process that removes lipids from algae biomass without harsh chemicals, reducing extraction costs and preserving product purity. Applied to Photon8's algae-derived products.

3Genetically Enhanced Algae Strains
CategoryBiological feedstock / Proprietary algae strains
Description

Genetically enhanced algae strains engineered to produce lipids preferentially, decoupling lipid content from growth rate. Used as the biological feedstock within Photon8's cultivation system.

4Omega-3 Products (upcoming)
CategoryNutritional ingredients / Omega-3 fatty acids
Description

Algae-derived Omega-3 fatty acid products intended for nutritional supplement and health-product manufacturers. Currently in pre-commercial preparation ahead of upcoming market entry.

5Algae Biomass Products (lipids, proteins, minerals)
CategoryIndustrial biomass / Sustainable feedstocks
Description

Algae biomass products containing lipids, proteins, and minerals produced via Photon8's autotrophic cultivation and chemical-free extraction platform, intended for sustainable-industry buyers across biofuels, agriculture, and carbon-capture applications.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Longstanding partnership with Dr. Paul Zimba at TAMU-CC. The Shell GameChanger Project brought the company to TAMU-CC facilities which include culturing facilities, Lab PFRs, and extensive analytical equipment. Outdoor PFRs are producing on grounds ahead of upcoming Omega-3 market entry. The company enjoys extended staff through its relationship with TAMU-CC.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with LSU provides exclusive technology in downstream processing, adding to the unique and chemical-free nature of Photon8's products.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

Cellana is an algae biotechnology company developing phototrophic and heterotrophic algae strains for omega-3, biofuel, and bioproducts. It is directly comparable to Photon8 as a smaller-scale player building integrated algae cultivation and downstream processing.

TypeBroad incumbent
Description

Cargill is one of the largest agricultural and aquafeed ingredient suppliers globally, with active interests in sustainable omega-3 sourcing. It is both a potential offtake partner and competitor to Photon8 in algae-based feed ingredients and biofuels.

TypeEmerging player
Description

Checkerspot is an algae-based biotechnology company that engineers proprietary strains to produce novel oils and ingredients (e.g., polyurethanes, performance ingredients). It overlaps with Photon8 in genetically enhanced algae strain development and oils commercialization.

4Synthetic Genomics
TypeEmerging player
Description

Synthetic Genomics (SGI) is a privately held synthetic biology company developing engineered algae and microbes for fuels, nutraceuticals, and industrial products. It is comparable to Photon8 as a fellow technology-led algae biotech venture pursuing multiple bio-product outputs.

TypeOthers
Description

BASF is a global industrial chemicals and biotech company exploring fermentation- and algae-based routes to specialty chemicals, including omega-3 oils. It is an adjacent ecosystem participant and potential strategic partner/licensor for Photon8's bio-based specialty oils.

TypeBroad incumbent
Description

Corbion is a global ingredient and industrial biotech company that produces AlgaPrime DHA (algae-based omega-3) alongside a broad portfolio of food ingredients and biochemicals. It operates at commercial scale and competes broadly with Photon8 in the omega-3 and bio-based chemicals space.

TypeDirect peer
Description

Veramaris is a DSM/Marine Oil joint venture producing algae-based EPA & DHA omega-3 oils for aquafeed and nutrition. It is the most direct commercial competitor to Photon8's planned algae-omega-3 offering, serving the same end markets with the same algae-derived product.

TypeDirect peer
Description

Mara Renewables develops and produces algae-based omega-3 oils (DHAgold, omega-3 DHA/EPA) from heterotrophic fermentation. It directly competes with Photon8 in algae-derived omega-3 for nutrition and aquafeed, with established commercial customers.

TypeBroad incumbent
Description

Royal DSM (now dsm-firmenich) is a major nutrition, health, and ingredients company with deep involvement in omega-3 via its Veramaris joint venture and broader nutrition portfolio. It is a major potential buyer/competitor for Photon8's algae-omega-3 output.

TypeDirect peer
Description

BioVeritas produces microbial (algae-derived) oils for omega-3 and oleochemical applications using proprietary strains and fermentation. It overlaps directly with Photon8 on single-cell oil and omega-3 platforms targeting food, feed, and biofuel markets.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Photon8

Algae-based biotechnology / Industrial biotech manufacturingphoton8.com

What Photon8 does

Photon8 is a privately held industrial biotechnology company headquartered in Corpus Christi, Texas, developing algae-based production systems for lipids, proteins, and minerals. The company uses autotrophic photosynthesis to convert photons, CO2, and waste-stream nutrients into algae biomass, with near-term planned market entry in Omega-3 fatty acid products targeting the nutritional supplements and health products segment. Operations are physically anchored at Texas A&M University-Corpus Christi (TAMU-CC), where the company runs culturing facilities, lab-scale reactors, and outdoor production units, and are supplemented by a partnership with Louisiana State University for exclusive downstream processing technology. The company has been supported by the Shell GameChanger program, which enabled the buildout at TAMU-CC.

Photon8 firmographics

Firmographics
Name
Photon8
Legal name
Photon8
Website
https://photon8.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Ownership category
akta.pro rank

Photon8 industry classification

Industry
Product category
Algae-based biotechnology / Industrial biotech manufacturing
NAICS
Aquaculture (1125), Aquaculture (11251)
akta.pro industry
PRIMARYAFAEAAAE
Seaweed & Algae Aquaculture (incl. microalgae)
Agriculture & Food Production/Animal Production & Aquaculture/Aquaculture (Fish & Shellfish Farming)
SECONDARYEUABAIAJ
Biological CO₂ Utilization (algae/biotech conversion to fuels, chemicals, proteins)
Energy, Utilities & Environment/Carbon & Climate Solutions (Carbon Markets, Offsets, CCS/CCUS)/CO₂ Utilization & Carbon-to-Value (E-fuels, Chemicals, Building Materials)
SECONDARYAFAJAHAF
Algae & Seaweed Proteins (Microalgae/Spirulina, Macroalgae)
Agriculture & Food Production/Food Ingredients & Additives/Proteins & Protein Ingredients (Plant/Animal Proteins, Protein Isolates/Concentrates)

Keywords

  • Algae biotechnology
  • Omega-3 production
  • Algae biomass cultivation
  • Carbon capture systems
  • Sustainable biofuels

Where Photon8 is headquartered

Location

Headquarters

HQ city
Corpus Christi
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Photon8 business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Technology or R&D, Operations, Personnel, Infrastructure

Revenue model

  1. Omega-3 Products: Upcoming market entry focusing on Omega-3 production derived from algae biomass. The company is developing its commercial production capabilities ahead of launch.
  2. Algae Biomass Products: Products containing lipids, proteins, and minerals extracted from autotrophic algae through proprietary processes.

Go-to-market motion1 record

Marketing channels1 record

Photon8 product offering

Product offering

Core offering

Photon8 develops and operates an algae-based biotechnology platform that uses proprietary Parallel Film Reactor (PFR) systems with Traveling Wave Technology to cultivate autotrophic algae, converting photons, CO2, and nutrients into biomass rich in lipids, proteins, and minerals. The company pairs this with genetically enhanced algae strains and a chemical-free Aqueous Extraction process, with upcoming market entry focused on Omega-3 fatty acid production for nutritional supplements and broader sustainable-industry applications.

Product overview

Photon8 offers an integrated algae cultivation and processing system centered on its Parallel Film Reactor (PFR) technology with Traveling Wave Technology for closed-system algae growth, combined with genetically enhanced algae strains optimized for lipid production, and Aqueous Extraction for chemical-free lipid recovery. The company is positioning for market entry in Omega-3s, positioning itself as a sustainable alternative to conventional algae biofuels and omega-3 production approaches.

Differentiator

Problem solved

Functional benefit

Products and services

  • Parallel Film Reactor (PFR) with Traveling Wave Technology Patent-pending closed algae cultivation system offering closed-system performance at under $10/m2, with full CO2 utilization and contamination resistance. Used by Photon8 and intended customers as the production backbone for algae-derived products.
  • Aqueous Extraction Process Chemical-free water-based lipid extraction process that removes lipids from algae biomass without harsh chemicals, reducing extraction costs and preserving product purity. Applied to Photon8's algae-derived products.
  • Genetically Enhanced Algae Strains Genetically enhanced algae strains engineered to produce lipids preferentially, decoupling lipid content from growth rate. Used as the biological feedstock within Photon8's cultivation system.
  • Omega-3 Products (upcoming) Algae-derived Omega-3 fatty acid products intended for nutritional supplement and health-product manufacturers. Currently in pre-commercial preparation ahead of upcoming market entry.
  • Algae Biomass Products (lipids, proteins, minerals) Algae biomass products containing lipids, proteins, and minerals produced via Photon8's autotrophic cultivation and chemical-free extraction platform, intended for sustainable-industry buyers across biofuels, agriculture, and carbon-capture applications.

Quantifiable outcome

  • 100x reduction in capital and operating expenses compared to conventional algae biofuel approaches
  • +2 more outcomes

Companies that use Photon8

Customer profile

Segments2 records

Ideal customer profiles2 records

Photon8 technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Photon8 partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • Texas A&M University-Corpus Christi (TAMU-CC)coreStrategic or Co-development PartnerLongstanding partnership with Dr. Paul Zimba at TAMU-CC. The Shell GameChanger Project brought the company to TAMU-CC facilities which include culturing facilities, Lab PFRs, and extensive analytical equipment. Outdoor PFRs are producing on grounds ahead of upcoming Omega-3 market entry. The company enjoys extended staff through its relationship with TAMU-CC.
  • Louisiana State University (LSU)coreTechnology or IntegrationPartnership with LSU provides exclusive technology in downstream processing, adding to the unique and chemical-free nature of Photon8's products.

Scale indicators2 records

Recent moves6 records

Expansion highlights4 records

Photon8 competitors and assessment

Company assessment

Emerging players

  • Cellana: Cellana is an algae biotechnology company developing phototrophic and heterotrophic algae strains for omega-3, biofuel, and bioproducts. It is directly comparable to Photon8 as a smaller-scale player building integrated algae cultivation and downstream processing.
  • Checkerspot: Checkerspot is an algae-based biotechnology company that engineers proprietary strains to produce novel oils and ingredients (e.g., polyurethanes, performance ingredients). It overlaps with Photon8 in genetically enhanced algae strain development and oils commercialization.
  • Synthetic Genomics: Synthetic Genomics (SGI) is a privately held synthetic biology company developing engineered algae and microbes for fuels, nutraceuticals, and industrial products. It is comparable to Photon8 as a fellow technology-led algae biotech venture pursuing multiple bio-product outputs.

Broad incumbents

  • Cargill: Cargill is one of the largest agricultural and aquafeed ingredient suppliers globally, with active interests in sustainable omega-3 sourcing. It is both a potential offtake partner and competitor to Photon8 in algae-based feed ingredients and biofuels.
  • Corbion: Corbion is a global ingredient and industrial biotech company that produces AlgaPrime DHA (algae-based omega-3) alongside a broad portfolio of food ingredients and biochemicals. It operates at commercial scale and competes broadly with Photon8 in the omega-3 and bio-based chemicals space.
  • dsm-firmenich (Royal DSM): Royal DSM (now dsm-firmenich) is a major nutrition, health, and ingredients company with deep involvement in omega-3 via its Veramaris joint venture and broader nutrition portfolio. It is a major potential buyer/competitor for Photon8's algae-omega-3 output.

Others

  • BASF: BASF is a global industrial chemicals and biotech company exploring fermentation- and algae-based routes to specialty chemicals, including omega-3 oils. It is an adjacent ecosystem participant and potential strategic partner/licensor for Photon8's bio-based specialty oils.

Direct peers

  • Veramaris: Veramaris is a DSM/Marine Oil joint venture producing algae-based EPA & DHA omega-3 oils for aquafeed and nutrition. It is the most direct commercial competitor to Photon8's planned algae-omega-3 offering, serving the same end markets with the same algae-derived product.
  • Mara Renewables: Mara Renewables develops and produces algae-based omega-3 oils (DHAgold, omega-3 DHA/EPA) from heterotrophic fermentation. It directly competes with Photon8 in algae-derived omega-3 for nutrition and aquafeed, with established commercial customers.
  • BioVeritas: BioVeritas produces microbial (algae-derived) oils for omega-3 and oleochemical applications using proprietary strains and fermentation. It overlaps directly with Photon8 on single-cell oil and omega-3 platforms targeting food, feed, and biofuel markets.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Photon8 social profiles

Digital presence

Photon8 financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Photon8 leadership team

Management profile

Number of profiles

Photon8 funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Photon8 M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Photon8

What does Photon8 do?

Photon8 develops and operates an algae-based biotechnology platform that uses proprietary Parallel Film Reactor (PFR) systems with Traveling Wave Technology to cultivate autotrophic algae, converting photons, CO2, and nutrients into biomass rich in lipids, proteins, and minerals. The company pairs this with genetically enhanced algae strains and a chemical-free Aqueous Extraction process, with upcoming market entry focused on Omega-3 fatty acid production for nutritional supplements and broader sustainable-industry applications.

Is Photon8 a public or private company?

Photon8 is a private company. It is classified as venture growth investor backed and is currently operating.

When was Photon8 founded?

Photon8 was founded in -1. It employs 1 to 10 people.

Where is Photon8 based?

Photon8 is headquartered in Corpus Christi, United States, in the North America region.

How does Photon8 make money?

Two revenue lines are on record. Omega-3 Products are the primary driver. The others are algae Biomass Products.

Who are Photon8's main competitors?

Emerging players on record are Cellana, Checkerspot and Synthetic Genomics. Broad incumbents are Cargill, Corbion and dsm-firmenich (Royal DSM). BASF is listed as an others. Direct peers are Veramaris, Mara Renewables and BioVeritas.

Does Photon8 have an API?

No public API is recorded for Photon8.

What industry is Photon8 in?

Photon8's product category is Algae-based biotechnology / Industrial biotech manufacturing. Its primary akta.pro industry code is AFAEAAAE, Seaweed & Algae Aquaculture (incl. microalgae), with a secondary code of EUABAIAJ, Biological CO₂ Utilization (algae/biotech conversion to fuels, chemicals, proteins). Its NAICS code is 1125.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales